134 related articles for article (PubMed ID: 38682845)
21. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases.
Mahler M; Fritzler MJ
Clin Dev Immunol; 2012; 2012():494356. PubMed ID: 23304189
[TBL] [Abstract][Full Text] [Related]
22. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
23. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
24. Anti-DFS70 antibodies detected by immunoblot methods: A reliable tool to confirm the dense fine speckles ANA pattern.
Bizzaro N; Pesente F; Cucchiaro F; Infantino M; Tampoia M; Villalta D; Fabris M; Tonutti E
J Immunol Methods; 2016 Sep; 436():50-3. PubMed ID: 27374867
[TBL] [Abstract][Full Text] [Related]
25. Subgroups of canine antinuclear antibodies in relation to laboratory and clinical findings in immune-mediated disease.
Hansson-Hamlin H; Lilliehöök I; Trowald-Wigh G
Vet Clin Pathol; 2006 Dec; 35(4):397-404. PubMed ID: 17123245
[TBL] [Abstract][Full Text] [Related]
26. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.
Peker BO; Şener AG; Tarhan EF; Kaya S
Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
[TBL] [Abstract][Full Text] [Related]
28. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
Duran A; Çetin Duran A; Taşkıran İ
Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
[TBL] [Abstract][Full Text] [Related]
29. Novel method for quantitative ANA measurement using near-infrared imaging.
Peterson LK; Wells D; Shaw L; Velez MG; Harbeck R; Dragone LL
J Immunol Methods; 2009 Sep; 349(1-2):1-8. PubMed ID: 19720064
[TBL] [Abstract][Full Text] [Related]
30. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
31. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
32. Novel method for ANA quantitation using IIF imaging system.
Peng X; Tang J; Wu Y; Yang B; Hu J
J Immunol Methods; 2014 Feb; 404():52-8. PubMed ID: 24370749
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of borderline results of the Elia CTD Screen assay.
Robier C; Amouzadeh-Ghadikolai O
Clin Chem Lab Med; 2018 Nov; 56(12):2088-2092. PubMed ID: 30032128
[TBL] [Abstract][Full Text] [Related]
34. Distinctive features of positive anti-cell antibody tests (indirect immunofluorescence on HEp-2 cells) in patients with non-autoimmune diseases.
Agustinelli RA; Rodrigues SH; Mariz HA; Prado MS; Andrade LEC
Lupus; 2019 Apr; 28(5):629-634. PubMed ID: 31027463
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases.
Dorofeev AS; Aleksandrova EN; Novikov AA; Saliev KG; Sandler YG; Vinnitskaya EV
Klin Lab Diagn; 2022 Nov; 67(11):652-657. PubMed ID: 36398774
[TBL] [Abstract][Full Text] [Related]
36. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.
Bentow C; Rosenblum R; Correia P; Karayev E; Karayev D; Williams D; Kulczycka J; Fritzler MJ; Mahler M
Lupus; 2016 Jul; 25(8):897-904. PubMed ID: 27252267
[TBL] [Abstract][Full Text] [Related]
37. The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern.
Dellavance A; Viana VS; Leon EP; Bonfa ES; Andrade LE; Leser PG
J Rheumatol; 2005 Nov; 32(11):2144-9. PubMed ID: 16265692
[TBL] [Abstract][Full Text] [Related]
38. The incidence of immunofluorescence patterns and specific autoantibodies observed in autoimmune patients in a tertiary care centre.
Chauhan R; Jain D; Dorwal P; Roy G; Raina V; Nandi S P
Eur Ann Allergy Clin Immunol; 2019 Jul; 51(4):165-173. PubMed ID: 30983307
[No Abstract] [Full Text] [Related]
39. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
[TBL] [Abstract][Full Text] [Related]
40. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
